Search Results 71-80 of 14733 for alt

1. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   ALT ≥ 5 × ULN: If a third serum ALT measurement is required, and both Screening Visit 2 and unscheduled visit ALT values are ≥ 0% higher than the ...

2. Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

   AST and ALT ≤3× ULN or < 5 ULN for patients with liver metastases. Able to understand and willing to sign an IRB approved written informed consent document ...

3. ACPE Application and Instructions for Clinical Pastoral Education

   ... Day Tel.: Alt Tel.: Fax: Permanent address ...

4. An Extension Study to Assess the Safety of the Use of Cannabidiol in Children and Young Adults with Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

   Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN] or total bilirubin [TBL] >2 x ULN; ALT or aspartate aminotransferase (AST) >3 x ULN and ...

5. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   ... (ALT) and aspartate transaminase (AST) ≤ 2.5 X ULN (upper limit of normal). Part 2 only: plasma total bilirubin ≤ ULN; ALT and/or AST ≤ 1.5 X ULN ...

6. A Multicenter Open Label Trial Using Ambrisentan in Patients with Porto-pulmonary Hypertension - Mayo Clinic

   Moribund state or anticipated death within 1 month. AST or ALT ≥ 5 times upper limit of normal; Total bilirubin ≥ 3.0 mg/dl; Significant lung disease ...

7. Publications - Lilly H. Wagner, M.D. - Mayo Clinic

   ... Alt E. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 2009 Jul 18; 280 (1):65-71 Epub 2009 Mar 14

8. PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes - Mayo Clinic

   ALT (SGPT) < 2 times upper limit of normal; Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl (except for Aim 4). Aim 4. Age 30 ...

9. Randomized Global Phase 3 Study to Evaluate the Impact of Obeticholic Acid Treatment on Nonalcoholic Steatohepatitis Patients - Mayo Clinic

   ALT >1.5 × upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E ...

10. Impact of CardiolRxTM on Recurrent Pericarditis - Mayo Clinic

    Elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 times the upper limit of normal (ULN) or ALT or AST >3x ULN plus bilirubin >2x ...